Prenetics Global achieved breakthrough growth in 2025 with revenue of approximately $92 million, primarily driven by IM8, its consumer-focused nutritional supplement brand. The brand achieved annual recurring revenue of $120 million, growing from approximately $581,000 in the first month to approximately $10 million in monthly revenue by December. IM8 achieved a gross margin of 63% in 2025, and the company projects 2026 revenue to reach $180 million to $200 million with gross margins at or exceeding 60%. Management has divested non-core assets and currently holds approximately $160 million in liquid assets with no debt, targeting profitability by Q4 2027.